ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the global launch of the Optisure™ Defibrillation Lead. This new lead is an addition to the company’s Optim™ lead family, joining the proven Durata™ Defibrillation Lead, which is supported by more than six years of implant experience and the most robust post-market surveillance monitoring in the industry.
Help employers find you! Check out all the jobs and post your resume.
